In patients with post- and precapillary pulmonary hypertension and heart failure with preserved ejection fraction, ...

AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...

Please provide your email address to receive an email when new articles are posted on . Advancements in treatment directed by risk stratification and the availability of novel targeted therapy provide ...

Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary arterial hypertension. Its effects in patients with pulmonary arterial ...

Nearly 50% of Americans have hypertension, a condition caused by high blood pressure. It is the top risk factor for heart disease and stroke, and increases the risk of dementia and cognitive decline.

An analysis of the 2025 AHA/ACC hypertension guidelines found that under the new guidelines, about 11% of adults ages 65 to 79 with stage I hypertension would no longer qualify for blood pressure ...

Narrowing of the blood vessels in the lung is the most important cause of pulmonary hypertension, as narrowed vessels reduce the space available for blood flow, causing pressure to rise. The acute ...